2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 41.926 | 44.123 | 34.309 | 32.646 | 23.160 | 27.248 | 35.826 | 55.960 | 33.114 | 83.612 |
Total Income - EUR | 41.929 | 45.001 | 40.011 | 36.422 | 23.167 | 27.248 | 36.000 | 57.235 | 33.114 | 83.613 |
Total Expenses - EUR | 36.573 | 30.957 | 24.226 | 35.820 | 19.186 | 21.239 | 19.935 | 36.083 | 31.819 | 60.083 |
Gross Profit/Loss - EUR | 5.355 | 14.044 | 15.784 | 602 | 3.981 | 6.010 | 16.065 | 21.152 | 1.295 | 23.530 |
Net Profit/Loss - EUR | 4.097 | 12.694 | 15.441 | 238 | 3.749 | 5.737 | 15.308 | 20.580 | 964 | 22.693 |
Employees | 5 | 5 | 5 | 3 | 2 | 2 | 0 | 2 | 3 | 2 |
Check the financial reports for the company - Ro Farmavet Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 16.670 | 15.632 | 14.307 | 10.824 | 9.609 | 10.021 | 13.467 | 11.133 | 10.019 | 34.575 |
Current Assets | 39.081 | 36.328 | 34.296 | 14.694 | 16.634 | 16.024 | 31.629 | 53.305 | 56.692 | 45.235 |
Inventories | 13.004 | 9.800 | 9.546 | 9.344 | 10.215 | 11.680 | 15.726 | 17.135 | 25.422 | 21.999 |
Receivables | 4.822 | 162 | 1.681 | 1.743 | 2.402 | 4.021 | 5.340 | 10.043 | 9.515 | 13.630 |
Cash | 21.255 | 26.366 | 23.069 | 3.606 | 4.018 | 323 | 10.563 | 26.127 | 21.754 | 9.606 |
Shareholders Funds | 23.864 | 36.757 | 47.135 | 23.533 | 24.588 | 23.195 | 38.063 | 57.798 | 58.942 | 34.959 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 31.888 | 15.203 | 1.468 | 1.985 | 1.655 | 2.849 | 7.034 | 6.640 | 7.769 | 34.942 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.908 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "7500 - 7500" | |||||||||
CAEN Financial Year |
7500
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Ro Farmavet Srl